Amount and Type of Dietary Fat, Postprandial Glycemia, and Insulin Requirements in Type 1 Diabetes: A Randomized Within-Subject Trial.


Journal

Diabetes care
ISSN: 1935-5548
Titre abrégé: Diabetes Care
Pays: United States
ID NLM: 7805975

Informations de publication

Date de publication:
01 2020
Historique:
received: 05 04 2019
accepted: 21 07 2019
pubmed: 29 8 2019
medline: 3 10 2020
entrez: 29 8 2019
Statut: ppublish

Résumé

The American Diabetes Association recommends individuals with type 1 diabetes (T1D) adjust insulin for dietary fat; however, optimal adjustments are not known. This study aimed to determine Adults with T1D using insulin pump therapy attended the research clinic on 9-12 occasions. On the first six visits, participants consumed meals containing 45 g carbohydrate with 0 g, 20 g, 40 g, or 60 g fat and either saturated, monounsaturated, or polyunsaturated fat. Insulin was dosed using individual insulin/carbohydrate ratio as a dual-wave 50/50% over 2 h. On subsequent visits, participants repeated the 20-60-g fat meals with the insulin dose estimated using a model predictive bolus, up to twice per meal, until glycemic control was achieved. With the same insulin dose, increasing the amount of fat resulted in a significant dose-dependent reduction in incremental area under the curve for glucose (iAUC This study provides clinical guidance for mealtime insulin dosing recommendations for dietary fat in T1D.

Identifiants

pubmed: 31455688
pii: dc19-0687
doi: 10.2337/dc19-0687
doi:

Substances chimiques

Blood Glucose 0
Dietary Fats 0
Insulin 0

Banques de données

ANZCTR
['ACTRN12617000828325']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

59-66

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2019 by the American Diabetes Association.

Auteurs

Kirstine J Bell (KJ)

Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia kirstine.bell@sydney.edu.au.

Chantelle Z Fio (CZ)

Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.

Stephen Twigg (S)

Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.
Royal Prince Alfred Hospital Diabetes Centre, Sydney, New South Wales, Australia.

Sally-Anne Duke (SA)

Royal North Shore Hospital Diabetes Centre, Sydney, New South Wales, Australia.

Gregory Fulcher (G)

Royal North Shore Hospital Diabetes Centre, Sydney, New South Wales, Australia.

Kylie Alexander (K)

Royal North Shore Hospital Diabetes Centre, Sydney, New South Wales, Australia.

Margaret McGill (M)

Royal Prince Alfred Hospital Diabetes Centre, Sydney, New South Wales, Australia.

Jencia Wong (J)

Royal Prince Alfred Hospital Diabetes Centre, Sydney, New South Wales, Australia.

Jennie Brand-Miller (J)

Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.

Garry M Steil (GM)

Harvard Medical School, Boston, MA.
Boston Children's Hospital, Boston, MA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH